Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05036291 · ClinicalTrials.gov registry record · Phase 1

A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by Ningbo Newbay Technology Development Co..

Recruiting
Registry status
Phase 1
Development phase
120
Enrollment target
4
Study locations

NCT05036291 is a Phase 1 study of Advanced Solid Tumor that is actively recruiting participants, run by Ningbo Newbay Technology Development Co.. The registered enrollment target is 120 participants, below the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (37% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05036291, a Phase 1 study of Advanced Solid Tumor, is actively recruiting participants, sponsored by Ningbo Newbay Technology Development Co..

RECRUITING
Registry status
Phase 1
Development phase
120 participants
Enrollment target
4
Study locations

Study Summary

This is a Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB004 Administered as Monotherapy or Combination Therapy in Subjects with Advanced Solid Tumors

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG NB004 tablets

Study Locations (4)

Taiwan

  • National Cheng Kung University Hospital（NCKUH） - Tainan
  • National Taiwan University Hospital Yunlin Branch - Yunlin

Louisiana

  • LSU-LCMC Health Cancer Center - New Orleans

Texas

  • The University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-10-01
Est. Completion 2026-09-01
Phase Phase 1

Sponsor

Ningbo Newbay Technology Development Co.

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05036291

The ClinicalTrials.gov registry entry for NCT05036291 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (37% lower). The listed sponsor is Ningbo Newbay Technology Development Co., which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which NB004 tablets is the first listed.

NCT05036291 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Taiwan, Louisiana, Texas.

Frequently Asked Questions

What is clinical trial NCT05036291 about?

NCT05036291 is a clinical study titled "A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors". This is a Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB004 Administered as Monotherapy or Combination Therapy in Subjects with Advanced Solid Tumors

What is the current status of trial NCT05036291?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2021-10-01. Estimated completion is 2026-09-01.

What conditions does trial NCT05036291 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT05036291?

The interventions under investigation include: NB004 tablets (DRUG).

Who is sponsoring clinical trial NCT05036291?

This trial is sponsored by Ningbo Newbay Technology Development Co., which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05036291 being conducted?

This trial has 4 study locations across Louisiana, Texas, Taiwan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Louisiana

All trials with a study site in Louisiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.